RecruitingPhase 1NCT06860802

Precision Antibiotic Dosing for Appendectomy

Aim 3 - Precision Coordination of Therapeutic and Prophylactic Antibiotics to Reduce Infection, Toxicity, and Emergence of Resistance Following Acute Abdominal Surgery


Sponsor

University of Michigan

Enrollment

46 participants

Start Date

Feb 28, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This research is studying a drug called cefoxitin already approved by the Food and Drug Administration (FDA) to reduce the risk of infection after surgery to remove an appendix. Researchers are studying a large group of people to continue to learn how best to dose antibiotics. This research will compare the current standard treatment which is a single dose prior to surgery to a new method that includes adding another dose of cefoxitin within 30 minutes of starting the surgery. This study will measure cefoxitin concentrations in blood, fat, and appendix tissue samples to compare the standard dosing method to our new method. This information will help us figure out the right dose of this drug to prevent infection after surgery to remove an appendix.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Diagnosis of acute appendicitis and plan to undergo appendectomy at the University of Michigan

Exclusion Criteria3

  • Prisoners
  • Patients that are pregnant
  • Patients with perforation or abscess on CT Scan

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCefoxitin

Cefoxitin 2000 mg Bolus Injection


Locations(1)

Michigan Medicine

Ann Arbor, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06860802